statistiche ricercatore

Continente	#
AS - Asia	741
NA - Nord America	741
EU - Europa	433
AF - Africa	59
Continente sconosciuto - Info sul continente non disponibili	36
SA - Sud America	31
OC - Oceania	2
Totale	2.043

Nazione	#
US - Stati Uniti d'America	730
VN - Vietnam	260
SG - Singapore	186
CN - Cina	146
GB - Regno Unito	98
SE - Svezia	67
DE - Germania	61
IT - Italia	55
HK - Hong Kong	53
FR - Francia	37
IN - India	36
RU - Federazione Russa	34
BR - Brasile	24
CI - Costa d'Avorio	18
IE - Irlanda	18
ZA - Sudafrica	15
JO - Giordania	14
NL - Olanda	14
TG - Togo	10
CA - Canada	9
CH - Svizzera	8
FI - Finlandia	8
JP - Giappone	8
BD - Bangladesh	6
EE - Estonia	6
PH - Filippine	6
KR - Corea	5
SC - Seychelles	5
BE - Belgio	4
PL - Polonia	4
TR - Turchia	4
BG - Bulgaria	3
ES - Italia	3
ID - Indonesia	3
NG - Nigeria	3
TH - Thailandia	3
UA - Ucraina	3
AR - Argentina	2
EC - Ecuador	2
HR - Croazia	2
IQ - Iraq	2
LT - Lituania	2
MA - Marocco	2
SA - Arabia Saudita	2
TN - Tunisia	2
TW - Taiwan	2
AM - Armenia	1
AT - Austria	1
AU - Australia	1
BY - Bielorussia	1
CL - Cile	1
EG - Egitto	1
ET - Etiopia	1
GA - Gabon	1
MX - Messico	1
MY - Malesia	1
NZ - Nuova Zelanda	1
PK - Pakistan	1
PT - Portogallo	1
RE - Reunion	1
RO - Romania	1
RS - Serbia	1
SK - Slovacchia (Repubblica Slovacca)	1
SY - Repubblica araba siriana	1
TT - Trinidad e Tobago	1
UY - Uruguay	1
UZ - Uzbekistan	1
VE - Venezuela	1
Totale	2.007

Nome	#
Prediction Nomogram for 68 Ga-PSMA-11 PET/CT in Different Clinical Settings of PSA Failure After Radical Treatment for Prostate Cancer	230
18f-fdg pet/ct for restaging gastric cancer after surgical resection	195
18F-FLT PET/CT in patients with advanced Non-Small Lung Cancer (NSCLC) treated with Nivolumab: preliminary results	184
The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence.	163
[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial.	156
11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series	155
Predictive accuracy and clinical benefit of a nomogram aimed to predict 68Ga-PSMA PET/CT positivity in patients with prostate cancer recurrence and PSA < 1 ng/ml external validation on a single institution database	152
A Rare Case of Epididymal Metastasis After Radical Prostatectomy Detected by 68Ga-PSMA PET/CT.	148
Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by 68 Ga-PSMA-11 PET/CT	135
Male Breast Cancer Detected by 68Ga-PSMA-11 PET/CT in a Patient With Prostate Cancer With Pelvic Lymph Node Metastasis.	128
null	119
The influence of PSA flare in mCRPC patients treated with alpha-emitting radiopharmaceuticals	117
Prognostic value of 68Ga-DOTA-NOC PET/CT SUVmax in patients with neuroendocrine tumours of the pancreas	106
null	55
Totale	2.043

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	204	0	12	10	24	26	11	6	12	11	6	52	34
2022/2023	291	19	35	17	34	23	24	11	17	68	10	17	16
2023/2024	49	7	12	1	2	9	8	0	1	1	1	4	3
2024/2025	292	14	31	20	28	51	12	22	8	0	12	9	85
2025/2026	652	67	42	43	44	68	36	61	29	158	79	13	12
2026/2027	19	14	5	0	0	0	0	0	0	0	0	0	0
Totale													2.043

CRIS Current Research Information System